Travere Therapeutics Q2 Adj. EPS $(0.10) Beats $(0.14) Estimate, Sales $169.584M Beat $159.589M Estimate

Benzinga Newsdesk www.benzinga.com Positive 84.2%

Neg 0% Neu 0% Pos 84.2%

Comments

No comments yet. Be the first!